Breadcrumb
  1. Home
  2. Data & Reporting
  3. Health Center COVID-19 Survey

Health Center COVID-19 Survey

National Summary Report

Latest data from May 19, 2023

HRSA uses the information collected to: optimize COVID-19 testing and vaccination; track health center capacity and the impact of COVID-19 on operations, patients, and staff; and better understand training and technical assistance, funding, and other health center resource needs.

Health Center COVID-19 Survey Tool Questions

Health Center COVID-19 Survey Tool User Guide

Health Center Program Look-Alike Survey Data for COVID-19

COVID-19 Health Center Survey Interactive Data Dashboards

View cumulative vaccination data nationally; by state, territory, and freely associated state; and among patients identified as racial and/or ethnic minorities. New data views: total vaccinations (all sources) and Health Center Vaccine Program (federal allocations only).

View COVID-19 testing data by race/ethnicity.

Note: The dashboard data are updated bi-weekly using Health Center COVID-19 Survey data.

Number of Health Center respondents = 1027 (75% of all Health Centers)

Data represents information provided by health centers funded through H80 grants from a single, specified bi-weekly reporting date as indicated above. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 74,915         
                  
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen)

67.70%                        

       

Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 5,671                        
      
Racial and/or Ethnic Minority Patients 67.08%                                       

Patients Tested by Race and Ethnicity

Race/Ethnicity Patients Tested by race and ethnicity, Virus Detection (PCR, antigen)2 Patients Tested Positive by race and ethnicity, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 29.66% 30.59%
White, Hispanic/Latino Patients 29.46% 27.12%
Black/African American, Non-Hispanic/Latino Patients

12.45%

16.84%
Black/African American, Hispanic/Latino Patients 1.34% 2.05%
Asian Patients3 2.67% 2.87%
American Indian/Alaska Native Patients3

2.14%

1.29%

Native Hawaiian/Other Pacific Islander Patients3 1.15% 0.72%
Patients with More Than One Race3 4.88% 6.08%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 8.08% 5.36%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 1.86% 1.59%
Unreported/Refused to Report Race and Ethnicity 6.30% 5.48%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 6,500                                                        
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 77.67%        
                                            
COVID-19 Immunization Series Completed 3,990                                                
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 75.44%                                         
   
COVID-19 Immunization Series Additional 23,956                                      
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 68.34%                
              

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 19.91% 21.88% 28.50%
White, Hispanic/Latino Patients 28.62% 28.12% 23.03%
Black/African American, Non-Hispanic/Latino Patients 14.08%

12.06%

11.23%
Black/African American, Hispanic/Latino Patients 1.52% 1.28% 0.91%
Asian Patients3 4.85%

6.52%

8.26%
American Indian/Alaska Native Patients3 1.17% 1.18% 2.67%
Native Hawaiian/Other Pacific Islander Patients3 1.35% 0.98% 0.82%
Patients with More Than One Race3 3.63% 3.41% 3.79%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 14.03% 13.66% 10.82%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 2.75% 2.66% 1.71%
Unreported/Refused to Report Race and Ethnicity

8.09%

8.27% 8.27%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 31.06%                                                   
1 to 24 Hours 33.79%                                                 
More Than 24 Hours 30.57%                                        
N/A 4.58%                          

Operations and Staff

Metrics Value
Percent of Health Centers Hosting Community-Based Events (Mobile Vans, Pop-Up Clinics, School-Based Sites, or Family Vaccination Clinics) 25.02%                               
     
         
Number of Community-Based Events 1,377                                      
Number of Collaboration Community-Based Events 585          
       
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 28.92%         
                     

Test Kit Distribution

Metrics Value
Percent of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program 41.87%
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 234,461

N95 Mask Distribution

Metrics Value
Percent of Health Centers that Distributed N95 Masks Received through the HRSA Health Center COVID-19 N95 Mask 14.31%
Number of N95 Masks Distributed through the HRSA Health Center COVID-19 N95 Mask Program 29,270

 

Oral Antiviral Medication Distribution

Metrics Value
Percent of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program 15.68%

 

Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication5 62.94%
 

Oral Antiviral Medication Distribution by Race and Ethnicity

Race/Ethnicity Value
White, Non-Hispanic/Latino Patients 27.69%
White, Hispanic/Latino Patients 33.01%
Black/African American, Non-Hispanic/Latino Patients 8.31%
Black/African American, Hispanic/Latino Patients 0.43%
Asian Patients3 7.14%
American Indian/Alaska Native Patients3 1.17%
Native Hawaiian/Other Pacific Islander Patients3 1.28%
Patients with More Than One Race3 4.90%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 6.71%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race)

1.70%

Unreported/Refused to Report Race and Ethnicity 7.67%

Oral Antiviral Medication Distribution by Population Type

Metrics Value
Migratory/Agricultural Workers 3.83%
Patients Experiencing Homelessness 1.49%
Patients Who Are Residents of Public Housing 7.99%
Patients with Limited English Proficiency

23.32%

Children Under 18 Years of Age 2.45%

Results from States and Territories

Select a measure on the dropdown menu to view by state or territory.

 


1 The reported number of patients tested does not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed: